Menopausal symptoms are one of the most prevalent and problematic consequences of cancer treatment. These symptoms can impair quality of life and function, and reduce the tolerability of endocrine therapy in breast cancer patients. This presentation will describe the evidence for safety and efficacy of non-hormonal therapies for menopausal symptoms and provide clinical guidance on accessing and utilising pharmacological and non-pharmacological approaches.